Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of everolimus on adult polycystic nephropathy: pilot study
2007-001503-38Phase 2Active
- Sponsor
- ASST Lecco
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of everolimus in autosomal dominant polycystic kidney disease (ADPKD) and congenital cystic kidney disease, sponsored by ASST Lecco. Primary endpoint: glomerular filtration rate at any visit. Started Jun 2008; status: active.
02
Drugs
everolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)congenital cystic kidney disease
Beyond the preview
Go deeper on 2007-001503-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001503-38.